Development of a novel niosomal system for oral delivery of Ginkgo biloba extract

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 421-430

  Jin, Ye ^a,d   Wen, Jingyuan ^b   Garg, Sanjay ^c   Liu, Da ^a   Zhou, Yulin ^a   Teng, Lirong ^a   Zhang, Weiyu ^d  

^a JILIN UNIVERSITY   (China)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^d CHANGCHUN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Flavonoid glycosides; Ginkgo biloba extract; In vivo distribution; Niosomes; Oral delivery

Indexed keywords

CHOLESTEROL; FLAVONOID GLYCOSIDE; GINKGO BILOBA EXTRACT; MANNITOL; NIOSOME; PHOSPHATE BUFFERED SALINE; POLYSORBATE 80; SORBITAN OLEATE;

ANGLE OF REPOSE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG HEART LEVEL; DRUG KIDNEY LEVEL; DRUG LUNG LEVEL; DRUG RELEASE; DRUG STABILITY; DRUG TISSUE LEVEL; FREEZE DRYING; GINKGO BILOBA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHILICITY; IN VITRO STUDY; IN VIVO STUDY; LIPOPHILICITY; MALE; MORPHOLOGY; NONHUMAN; PARTICLE SIZE; PH; RAT; SINGLE DRUG DOSE; SPRAY DRYING; SUSPENSION; SUSTAINED RELEASE FORMULATION; TABLET FORMULATION; THERMOSTABILITY; ZETA POTENTIAL;

FLAVONOID GLYCOSIDES; GINKGO BILOBA EXTRACT; IN VIVO DISTRIBUTION; NIOSOMES; ORAL DELIVERY;

ADMINISTRATION, ORAL; ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; DRUG STABILITY; FLAVONOIDS; GINKGO BILOBA; GLYCOSIDES; LIPOSOMES; MALE; PARTICLE SIZE; PLANT EXTRACTS; RATS; RATS, WISTAR; TABLETS; TISSUE DISTRIBUTION;

EID: 84873049232     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S37984     Document Type: Article

References (47)

1. Singh B, Kaur P, Gopichand, Singh RD, Ahuja PS. Biology and chemistry of ginkgo biloba. Fitoterapia. 2008;79:401-418.
2. Ellnain-Wojtaszek M, Kruczyński Z, Kasprzak J. Investigation of the free radical scavenging activity of ginkgo biloba l. Leaves. Fitoterapia. 2003;74:1-6.
3. Goh LM, Barlow PJ, Yong CS. Examination of antioxidant activity of Ginkgo biloba leaf infusions. Food Chem. 2003;82:275-282.
4. Kawaii S, Tomono Y, Katase E, Ogawa K, Yano M. Antiproliferative activity of flavonoids on several cancer cell lines. Biosci Biotechnol Biochem. 1999;63:896-899.
5. Oyama Y, Chikahisa L, Ueha T, Kanemaru K, Noda K. Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide. Brain Res. 1996;712:349-352.
6. Oken BS, Storzbach DM, Kaye JA. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol. 1998;55: 1409-1415.
7. van Dongen M, van Rossum E, Kessels A, Sielhorst H, Knipschild P. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial. J Clin Epidemiol. 2003;56: 367-376.
8. Burschka MA, Hassan HA, Reineke T, van Bebber L, Caird DM, Mösges R. Effect of treatment with Ginkgo biloba extract EGB 761 (oral) on unilateral idiopathic sudden hearing loss in a prospective randomized double-blind study of 106 outpatients. Eur Arch Otorhinolaryngol. 2001;258:213-219.
9. van Beek TA. Chemical analysis of Ginkgo biloba leaves and extracts. J Chromatogr A. 2002;967:21-55.
10. Mesbah MK, Khalifa SI, El-Gindy A, Tawfik KA. Hplc determination of certain flavonoids and terpene lactones in selected Ginkgo biloba L. Phytopharmaceuticals. Farmaco. 2005;60:583-590.
11. Drago F, Floriddia ML, Cro M, Giuffrida S. Pharmacokinetics and bioavailability of a ginkgo biloba extract. J Ocul Pharmacol Ther. 2002;18:197-202.
12. Yamamoto S, Nakano K, Ishikawa C, etal. Enhanced inhibitory effects of extracts from ginkgo biloba L. Leaves encapsulated in hybrid liposomes on the growth of tumor cells in vitro. Biochem Eng J. 2002;12:125-130.
13. Chen ZP, Sun J, Chen HX, etal. Comparative pharmacokinetics and bioavailability studies of quercetin, kaempferol and isorhamnetin after oral administration of ginkgo biloba extracts, ginkgo biloba extract phospholipid complexes and ginkgo biloba extract solid dispersions in rats. Fitoterapia. 2010;81:1045-1052.
14. Garcia-Garcia E, Andrieux K, Gil S, Couvreur P. Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain? Int J Pharm. 2005;298:274-292.
15. Manosroi A, Wongtrakul P, Manosroi J, et al. Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surf B Biointerfaces. 2003;30:129-138.
16. Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 1998;172:33-70.
17. Vora B, Khopade AJ, Jain NK. Proniosome based transdermal delivery of levonorgestrel for effective contraception. J Control Release. 1998;54:149-165.
18. Sinha V, Singh A, Kumar RV, Singh S, Kumria R, Bhinge J. Niosomes for oral delivery of peptide drugs. J Control Release. 1992;21:145-153.
19. Terzano C, Allegra L, Alhaique F, Marianecci C, Carafa M. Non-phospholipid vesicles for pulmonary glucocorticoid delivery. Eur J Pharm Biopharm. 2005;59:57-62.
20. Manosroi A, Jantrawut P, Manosroi J. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac. Int J Pharm. 2008;360:156-163.
21. Pardakhty A, Varshosaz J, Rouholamini A. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm. 2007;328:130-141.
22. Farkas E, Schubert R, Zelkó R. Effect of β-sitosterol on the characteristics of vesiculargels containing chlorhexidine. Int J Pharm. 2004;278:63-70.
23. Walker W, Brewer JM, Alexander J. Lipid vesicle-entrapped influenza a antigen modulates the influenza A-specific human antibody response in immune reconstituted scid-human mice. Eur J Immunol. 1996;26: 1664-1667.
24. Manconi M, Sinico C, Valenti D, Loy G, Fadda AM. Niosomes as carriers for tretinoin. I. Preparation and properties. Int J Pharm. 2002;234:237-248.
25. Gupta A, Prajapati SK, Singh M, Balamurugan M. Proniosomal powder of captopril: formulation and evaluation. Mol Pharm. 2007;4:596-599.
26. Mukherjee B, Patra B, Layek B, Mukherjee A. Sustained release of acyclovir from nano-liposomes and nano-niosomes: an in vitro study. Int J Nanomedicine. 2007;2:213-225.
27. Arunothayanun P, Bernard MS, Craig DQ, Uchegbu IF, Florence AT. The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether. Int J Pharm. 2000;201:7-14.
28. Fang JY, Yu SY, Wu PC, Huang YB, Tsai YH. In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm. 2001;215:91-99.
29. Tank CJ, Borkhataria CH, Baria AH, Patel RP. Formulation and evaluation of aceclofenac loaded maltodextrin based proniosome. International Journal of ChemTech Research. 2009;1:567-573.
30. Klajnert B, Janiszewska J, Urbanczyk-Lipkowska Z, Bryszewska M, Epand RM. DSC studies on interactions between low molecular mass peptide dendrimers and model lipid membranes. Int J Pharm. 2006;327: 145-152.
31. Saarinen-Savolainen P, Jarvinen T, Taipale H, Urtti A. Method for evaluating drug release from liposomes in sink conditions. Int J Pharm. 1997;159:27-33.
32. Shahiwala A, Misra A. Studies in topical application of niosomally entrapped nimesulide. J Pharm Pharm Sci. 2002;5:220-225.
33. Parthasarathi G, Udupa N, Umadevi P, Pillai GK. Niosome encapsulated of vincristine sulfate: improved anticancer activity with reduced toxicity in mice. J Drug Target. 1994;2:173-182.
34. Arunothayanun P, Uchegbu IF, Craig DQ, Turton JA, Florence AT. In vitro/in vivo characterisation of polyhedral niosomes. Int J Pharm. 1999;183:57-61.
35. Devaraj GN, Parakh SR, Devraj R, Apte SS,Rao BR, Rambhau D. Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol. J Colloid Interface Sci. 2002;251:360-365.
36. Junyaprasert VB, Teeranachaideekul V, Supaperm T. Effect of charged and non-ionic membrane additives on physicochemical properties and stability of niosomes. AAPS Pharm Sci Tech. 2008;9:851-859.
37. Naresh A, Vipin S, Vijay KB, et al. Formulation and evaluation of lansoprazole niosome. Rasayan Journal of Chemistry. 2008;1: 561-563.
38. Guinedi AS, Mortada ND, Mansour S, Hathout RM. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm. 2005;306:71-82.
39. Srinivas S, Kumar YA, Hemanth A, Anitha M. Preparation and evaluation of niosomes containing aceclofenac. Digest Journal of Nanomaterials and Biostructures. 2010;5:249-254.
40. Fry DW, White JC, Goldman ID. Rapid separation of low molecular weight solutes from liposomes without dilution. Anal Biochem. 1978;90: 809-815.
41. Sun W-T, Huang G, Ye J-S, Zhang N. Determination of encapsulation efficiencies of liposomes and nanoliposomes by protamine aggregation method. Chinese Pharmaceutical Journal. 2006;41:1716-1719.
42. Suo X-B, Deng Y-J, Jing S-Q, et al. Determination of the entrapment efficiency of astragaloside liposome with HPLC-ELSD and macroreticular resin. Chinese Pharmaceutical Journal. 2004;40: 680-681.
43. Hu C, Rhodes DG. Proniosomes: A novel drug carrier preparation. Int J Pharm. 1999;185:23-35.
44. Ge Y. An investigation into the mechanisms of rapid release of standard extract from ginkgo biloba leaf in polyethylene glycol 6000 solid dispersions. Yakugaku Zasshi. 2010;130:425-430.
45. Wang M, Yuan Y, Gao Y, et al. Preparation and characterization of 5-fluorouracil pH-sensitive niosome and its tumor-targeted evaluation: in vitro and in vivo. Drug Dev Ind Pharm. 2012;38:1134-1141.
46. Lalloo A, Chao P, Hu P, Stein S, Sinko PJ. Pharmacokinetic and pharmacodynamic evaluation of a novel in situ forming poly(ethylene glycol)-based hydrogel for the controlled delivery of the camptothecins. J Control Release. 2006;112:333-342.
47. Teixeira RS, Curi R, Maranhão RC. Effects on Walker 256 tumour of carmustine associated with a cholesterol-rich microemulsion (LDE). J Pharm Pharmacol. 2004;56:909-914.